Cargando…
HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor
Autores principales: | Goffinet, Christine, Allespach, Ina, Homann, Stefanie, Tervo, Hanna-Mari, Habermann, Anja, Rupp, Daniel, Oberbremer, Lena, Kern, Christian, Tibroni, Nadine, Welsch, Sonja, Krijnse-Locker, Jacomine, Banting, George, Kräusslich, Hans-Georg, Fackler, Oliver T, Keppler, Oliver T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766964/ http://dx.doi.org/10.1186/1742-4690-6-S2-O10 |
Ejemplares similares
-
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release
por: Tervo, Hanna-Mari, et al.
Publicado: (2011) -
HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages
por: Welsch, Sonja, et al.
Publicado: (2007) -
HIV-1 Vpu Blocks Recycling and Biosynthetic Transport of the Intrinsic Immunity Factor CD317/Tetherin To Overcome the Virion Release Restriction
por: Schmidt, Sarah, et al.
Publicado: (2011) -
Expression of HIV-1 Vpu Leads to Loss of the Viral Restriction Factor CD317/Tetherin from Lipid Rafts and Its Enhanced Lysosomal Degradation
por: Rollason, Ruth, et al.
Publicado: (2013) -
In vivo-expression profile and regulation of the antiviral restriction factor CD317/tetherin in humans
por: Erikson, Elina, et al.
Publicado: (2011)